Education
Addyi (flibanserin) Update
Addyi will be available in pharmacies on October 17th. The medical staff at Maze is all set to prescribe Addyi. We have passed the required
Tara Ford, PA-C
October 10, 2015
Tag: flibanserin
Maze Women’s Health is dedicated to providing quality blog content, all written by our team of experts, to help you gain a better understanding about your sexual & reproductive health.
Education
Addyi (Flibanserin) approved by the FDA.
Addyi, also known as Flibanserin, was recently approved by the FDA to treat low sexual desire in women. It is the first FDA approved medication
Tara Ford, PA-C
August 28, 2015
Education
Why the FDA approval of Flibanserin is important.
Here is the most significant thing to remember: sex is not just about what happens in the bedroom. My friend used to say that sex
Bat Sheva Marcus, LMSW, MPH, PhD
August 19, 2015
Education
Flibanserin.
Dr. Steven Snyder is a sex therapist as well as a medical doctor and wrote this excellent article about Flibanserin in Psychology Today, the so-called
Tara Ford, PA-C
June 18, 2015
Education
Nothing is wrong with your sex drive?!?! Give me a break!
In a recent article in the New York Times entitled “Nothing Is Wrong With Your Sex Drive”, the author gave her opinion on the drug
Barbara Gross, LMSW
April 29, 2015
Education
What is Flibanserin?
I think this is a great article that talks about the medication Flibanserin and the controversy surrounding FDA approval for medications to treat female sexual
Tara Ford, PA-C
March 5, 2015
Librido: Can drugs help a woman’s desire?
There has been a lot of media attention recently on the advent of 2 new drugs being tested for female sexual dysfunction: Lybrido and Lybridos.
Bat Sheva Marcus, LMSW, MPH, PhD
July 12, 2013
Have the sex life you desire.
Daniel Bergner, is a contributor for the New York Times Magazine and author of several books including, The Other Side of Desire, which I loved.
Barbara Gross, LMSW
June 11, 2013
A pill for low libido?
There was a recent article in The New York Times Magazine that has generated some buzz in the field of human sexuality. The article was
Tara Ford, PA-C
June 5, 2013
Our sexual culture and The New York Times.
The latest public figure to make journalistic hay from the flibanserin controversy is Camille Paglia, whose editorial in The New York Times, ”No Sex Please,
Stephen Snyder, MD
July 9, 2010
Categories
Archives
Authors